7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Azitra Inc
(NYSE MKT:AZTR) 

AZTR stock logo

Azitra Inc, a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. The company is headquartered in Branford, Connecticut.

Founded: 2014
Sector: TECHNOLOGY
Industry: GENERAL

Share this website to your friends
Azitra Days Receivable Outstanding ttm (DSO)
202311 202312 202401 202402 202403 202404 016.9933.9750.9667.9584.93101.92118.9
Azitra Op Cashflow Per Share ttm
202311 202312 202401 202402 202403 202404 -0.84-0.72-0.6-0.48-0.36-0.24-0.120
Azitra Free Cashflow Per Share ttm
202311 202312 202401 202402 202403 202404 -0.87-0.74-0.62-0.5-0.37-0.25-0.120
Azitra Cash Per Share ttm
202311 202312 202401 202402 202403 202404 00.050.10.160.210.260.310.36
Azitra P/S ratio ttm
202311 202312 202401 202402 202403 202404 03.567.1210.6814.2317.7921.3524.91
Azitra (GAAP) P/E ratio ttm
202311 202312 202401 202402 202403 202404 -1.21-1.04-0.87-0.69-0.52-0.35-0.170
Azitra P/B ratio ttm
202311 202312 202401 202402 202403 202404 00.420.841.251.672.092.512.93
No extra charts and metrics for this ticker.